Reports

Reports
Global Peptide Therapeutics Market & Clinical Trials Insight 2022
Published
Number of pages
1300

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report gives comprehensive insight into the various clinical and non-clinical issues involved in the development of global peptide drug market. In recent years, peptides have emerged as one of the important classes of therapeutic molecules which have been developed by varied pharmaceutical and biotech companies in order to attain a targeted drug discovery for several ailments. As per report findings, there are 688 peptide drugs in clinical pipeline and more than 100 peptide based drugs commercially available in the market. Research and development of peptide based therapeutics has gained significant momentum

Reports
Global Orphan Drug Clinical Pipeline Insight 2022
Published
Number of pages
2200

“Global Orphan Drug Clinical Pipeline Insight 2022” report gives comprehensive insight on various clinical and non-clinical aspects associated with ongoing clinical trials of 808 orphan designated drugs across the globe. The in-depth clinical insight presented in the report helps the reader to analyze and identify the various stakeholders involved in the clinical development and commercialization of orphan designated drugs in the global market. Currently there are more than 300 orphan designated drugs commercially available in the global market and around 800 drugs in clinical development phase. As of 2016, almost 30 million people in the U.S. and 350 million people

Reports
Yuhan Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
22

“Yuhan - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Yuhan. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “11” cancer drugs in clinical pipeline. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status, Clinical Introduction, Drug Formulation/ Route, Owner/License, Multiple Development Phase

Reports
XOMA Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
33

“XOMA - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by XOMA. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “2” cancer drugs in clinical pipeline.The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status, Clinical Introduction, Drug Formulation/ Route, Owner/License, Multiple Development Phase of

Reports
Yakult Honsha Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
44

“Yakult Honsha - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Yakult Honsha. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “5” cancer drugs in clinical pipeline and majority of them are in phase-II. There are 3 cancer drugs by Yakult Honsha which are commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and

Reports
Nippon Kayaku Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
84

“Nippon Kayaku - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Nippon Kayaku. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline and majority of them are in phase-II. There are 10 cancer drugs by Nippon Kayaku which are commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and

Reports
Onco Therapy Science Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
52

“Onco Therapy Science - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Onco Therapy Science. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “16” cancer drugs in clinical pipeline and majority of them are in preclinical phase.The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track

Reports
OPKO Health Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
30

“OPKO Health - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by OPKO Health. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “6” cancer drugs in clinical pipeline. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and information points like Drug Class, Mechanism of Action, Granted Orphan Designation, Fast Track Development Status, Clinical Introduction, Drug Formulation/ Route, Owner/License, Multiple

Reports
Otsuka Pharmaceutical Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
167

“Otsuka Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Otsuka Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “21” cancer drugs in clinical pipeline and majority of them are in phase-II. There are 10 cancer drugs by Otsuka Pharmaceuticals which are commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data and

Reports
Peregrine Pharmaceuticals Cancer Drugs Clinical Pipeline Insight
Published
Number of pages
47

“Peregrine Pharmaceuticals - Cancer Drugs Clinical Pipeline Insight” offers in depth insight on ongoing clinical trials for the cancer drugs developed by Peregrine Pharmaceuticals. This report highlights various clinical and non-clinical parameters involved in the development of cancer drugs in clinical pipeline. Currently there are “7” cancer drugs in clinical pipeline and majority of them are in preclinical phase. There is 1 cancer drug by Peregrine Pharmaceuticals which is commercially available in the market. The report includes all the relevant information with respect to development of cancer drugs in the clinical pipeline. Report helps the reader in identifying various data